Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
110.00    -4.50 (-3.93%)
Bid:
107.00
Ask:
113.00
Spread: 6.00 (5.607%)
Market Cap: £14.83m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Half-Year Trading Update

17 Jul 2019 07:00

RNS Number : 7572F
Itaconix PLC
17 July 2019
 

 

17 July 2019

Itaconix plc ("Itaconix" or the "Company")

Half-Year Trading Update

Itaconix (AIM: ITX), a leading innovator in sustainable specialty polymers, is pleased to announce the following trading update for the six-month period ended 30 June 2019.

Demand for the Company's proprietary detergent, odour control and hair styling polymers continued to grow from steady penetration of their use as key functional ingredients in an increasing range of everyday consumer product formulations for home and personal care.

As a result, unaudited revenues for the first half of 2019 grew to £0.5 million, which reflects a 59% increase over the same period in 2018 and a 33% increase compared to the second half of 2018. First half revenues also represent 72% of revenues for the previous full year.

Unaudited EBITDA(1) was a loss of £1.0 million, compared to a loss of £2.4 million for the same period in 2018 and a loss of £1.4 million for the second half of 2018. These reduced losses reflect the success of the Company's efforts to reduce the overall cost base while growing revenues.

Net cash as at 30 June 2019 was £1.5 million. Net cash as at 31 December 2018 was £2.1 million.

In addition to increased revenues and reduced EBITDA losses, the Company achieved important commercial milestones to support continued growth:

· Completed two global supply agreements with Nouryon for Itaconix detergent and hair styling polymers;

· Delivered the first purchase order of Itaconix® CHT™ 122 for use in a European non-phosphate automatic dish detergent; and

· Completed the divestment of its legacy nicotine gum business with the sale of its interest in Alkalon A/S for £0.2 million.

With this first half financial performance and commercial progress, the Board believes the Company is currently on track to meet market expectations for the full year.

John R. Shaw, CEO of Itaconix, stated: "Revenues for the first half of 2019 show a growing base of end-product formulations where our polymers are delivering key functional advantages. Use of our polymers in increasingly broader categories of consumer products has established the foundation for many years of revenue growth, especially when combined with the global reach of our partners."

1 Earnings before interest, tax, depreciation and amortisation.

Ends

For further information please contact:

Itaconix

+1 (603) 775 4400

 

John R. Shaw

N+1 Singer

+44 (0) 207 496 3000

Richard Lindley / James Moat (Corporate Finance)

Mia Gardner (Corporate Broking)

 

About Itaconix

Itaconix plc is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability.

www.itaconix.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTDXGDRBGBBGCL
Date   Source Headline
20th May 20197:00 amRNSBoard Change
3rd May 20197:00 amRNSFirst European Order for New Detergent Polymer
2nd Apr 20194:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20192:05 pmRNSSecond Price Monitoring Extn
28th Feb 20192:00 pmRNSPrice Monitoring Extension
28th Feb 20199:00 amRNSPersonal care agreement with Nouryon
18th Feb 201911:06 amRNSSecond Price Monitoring Extn
18th Feb 201911:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSFull Year Trading Update
15th Jan 20194:40 pmRNSSecond Price Monitoring Extn
15th Jan 20194:35 pmRNSPrice Monitoring Extension
15th Jan 20199:00 amRNSDetergent polymer agreement with Nouryon
9th Jan 20192:20 pmRNSBlock listing Interim Review
5th Dec 20187:00 amRNSNew Licence Agreement with New Wave
26th Oct 20187:00 amRNSDirectorate Change
2nd Oct 20187:00 amRNSBoard Changes
27th Sep 20187:00 amRNSInterim results
9th Aug 20181:41 pmRNSResult of AGM
6th Aug 20187:00 amRNSAppointment of Interim Chief Financial Officer
3rd Aug 20188:51 amRNSDirector/PDMR Dealings
3rd Aug 20188:47 amRNSBoard Changes
2nd Aug 201812:49 pmRNSExercise of Options, Directors' Dealing & TVR
2nd Aug 201811:57 amRNSResult of General Meeting
1st Aug 201810:02 amRNSResult of Open Offer & US Additional Subscription
16th Jul 20187:30 amRNSRestoration - Itaconix plc
13th Jul 20183:58 pmRNSReplacement re Further Details on the Fundraising
13th Jul 20183:54 pmRNSBlock listing Interim Review
13th Jul 20183:26 pmRNSRestoration of Trading
13th Jul 201812:11 pmRNSPosting of Circular & Annual Report & Notice of GM
12th Jul 20184:47 pmRNSFurther Details on the Fundraising
12th Jul 20187:05 amRNSProposed Fundraising
12th Jul 20187:00 amRNSPreliminary Results
29th Jun 20187:30 amRNSSuspension - Itaconix Plc
29th Jun 20187:30 amRNSSuspension of Share Trading and Financing Update
30th May 201810:00 amRNSOperational Update
16th May 20187:00 amRNSJoint marketing effort defined with AkzoNobel
16th Apr 20187:25 amRNSQ1 2018 Trading Update
13th Feb 20187:00 amRNSTrading Update
1st Feb 20187:00 amRNSBlock listing Interim Review
25th Jan 20187:00 amRNSLicence and assignment agreement with tremco
16th Oct 20179:00 amRNSSocietà Chimica Bussi investing in capacity
18th Sep 20177:00 amRNSInterim Results
5th Sep 20179:04 amRNSBio-based chelates for the detergents industry
26th Jul 20172:00 pmRNSFirst Bio-based Polymer Application Agreement
10th Jul 20177:00 amRNSBlock listing Interim Review
1st Jun 20171:19 pmRNSGrant of options
25th May 201712:42 pmRNSResult of AGM
18th May 20177:00 amRNSOperational Update
26th Apr 201711:01 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.